Fiamma Salerno BIO 2024

Fiamma Salerno completed her PhD research in the lab of Dr. Monika Wolkers (Sanquin Research, Amsterdam, NL), where she studied the role of post-transcriptional regulation in controlling cytokine production of effector, memory, and tumor-infiltrating CD8 T cells. After graduating cum laude in 2018, she obtained an EMBO long-term fellowship to join the lab of Dr. Martin Turner at the Babraham Institute of Cambridge (UK), where she complemented her wet-lab skills with training in bioinformatics. In 2021 she continued her research in the Turner lab as a Marie Skłodowska-Curie post-doctoral fellow to elucidate how RNA-binding proteins control B cell fate decisions that generate long-term immunity. Since January 2023, she returned to the Netherlands as a Tenure-track Group Leader and Assistant Professor at the Leiden University Medical Center (LUMC, Leiden, NL). Her research team combines in vivo mouse models, single-cell technologies and in vitro biochemical assays to study how membrane receptor signaling dictates T and B cell fate decisions through regulation of RNA translation. Her work is currently funded by the 2021 NWO-VENI-grant and the 2023 LUMC Gisela Thier Fellowship.

 

ORCID: https://orcid.org/0000-0002-8595-4051

WEBSITE: https://immunology.lumc.nl/research/tumor-biology-and-immunology-8/fiamma-salerno-479

X (TWITTER): https://twitter.com/SalernoFiamma